Detalles de la búsqueda
1.
Autoantibodies against angiotensin-converting enzyme 2 (ACE2) after COVID-19 infection or vaccination.
J Med Virol
; 95(12): e29313, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38100626
2.
Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant-Associated Receptor Binding Domain (RBD) Mutations on the Susceptibility to Serum Antibodies Elicited by Coronavirus Disease 2019 (COVID-19) Infection or Vaccination.
Clin Infect Dis
; 74(9): 1623-1630, 2022 05 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34309648
3.
Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant by Sera From BNT162b2 or CoronaVac Vaccine Recipients.
Clin Infect Dis
; 75(1): e822-e826, 2022 08 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-34915551
4.
Probable Animal-to-Human Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Delta Variant AY.127 Causing a Pet Shop-Related Coronavirus Disease 2019 (COVID-19) Outbreak in Hong Kong.
Clin Infect Dis
; 75(1): e76-e81, 2022 08 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-35234870
5.
Development and evaluation of a conventional RT-PCR for differentiating emerging influenza B/Victoria lineage viruses with hemagglutinin amino acid deletion from B/Yamagata lineage viruses.
J Med Virol
; 92(3): 382-385, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31608480
6.
Discovery of the FDA-approved drugs bexarotene, cetilistat, diiodohydroxyquinoline, and abiraterone as potential COVID-19 treatments with a robust two-tier screening system.
Pharmacol Res
; 159: 104960, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32473310
7.
Improved Detection of Antibodies against SARS-CoV-2 by Microsphere-Based Antibody Assay.
Int J Mol Sci
; 21(18)2020 Sep 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32916926
8.
Assessment of population susceptibility to upcoming seasonal influenza epidemic strain using interepidemic emerging influenza virus strains.
Epidemiol Infect
; 147: e279, 2019 09 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-31556360
9.
Characterizing fitness and immune escape of SARS-CoV-2 EG.5 sublineage using elderly serum and nasal organoid.
iScience
; 27(5): 109706, 2024 May 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38660398
10.
Effect of vaccine booster, vaccine type, and hybrid immunity on humoral and cellular immunity against SARS-CoV-2 ancestral strain and Omicron variant sublineages BA.2 and BA.5 among older adults with comorbidities: a cross sectional study.
EBioMedicine
; 88: 104446, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36706582
11.
Intranasal Boosting with Spike Fc-RBD of Wild-Type SARS-CoV-2 Induces Neutralizing Antibodies against Omicron Subvariants and Reduces Viral Load in the Nasal Turbinate of Mice.
Viruses
; 15(3)2023 03 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36992395
12.
Broad-spectrum humanized monoclonal neutralizing antibody against SARS-CoV-2 variants, including the Omicron variant.
Front Cell Infect Microbiol
; 13: 1213806, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37645378
13.
Determination of seroprevalence and kinetics of humoral response using mpox virus A29 protein.
Commun Med (Lond)
; 3(1): 168, 2023 Nov 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37993690
14.
Humoral and cellular immunity against different SARS-CoV-2 variants in patients with chronic kidney disease.
Sci Rep
; 13(1): 19932, 2023 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37968273
15.
Rational design of a booster vaccine against COVID-19 based on antigenic distance.
Cell Host Microbe
; 31(8): 1301-1316.e8, 2023 08 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37527659
16.
The viral fitness and intrinsic pathogenicity of dominant SARS-CoV-2 Omicron sublineages BA.1, BA.2, and BA.5.
EBioMedicine
; 95: 104753, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37579626
17.
Interferon-gamma inhibits influenza A virus cellular attachment by reducing sialic acid cluster size.
iScience
; 25(4): 104037, 2022 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35330686
18.
SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells.
Emerg Microbes Infect
; 11(1): 277-283, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34951565
19.
SARS-CoV-2 IgG seropositivity after the severe Omicron wave of COVID-19 in Hong Kong.
Emerg Microbes Infect
; 11(1): 2116-2119, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35880656
20.
Omicron variant susceptibility to neutralizing antibodies induced in children by natural SARS-CoV-2 infection or COVID-19 vaccine.
Emerg Microbes Infect
; 11(1): 543-547, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35084295